Tagged U.S Organic Cotton Expected at Retail Spring 2018

STONY BROOK, N.Y. (August 24, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that one of their ginning partners, the Woolam Gin in O’Donnell, Texas, was awarded the Global Organic Textile Standard (“GOTS v5.0”) certification, making it the first certified U.S. organic cotton gin utilizing Applied DNA’s molecular tagging system, which provides a single platform to tag, test, and track the organic cotton fibers throughout a certified supply chain. According to Control Union Certifications, a global certification body, Woolam Gin is 100 percent compliant with all standards and requirements for the GOTS v5.0 audit. Those standards and requirements examine the high level environmental criteria for processing organics, as well as socially responsible manufacturing practices. The GOTS certification coupled with USDA’s National Organic Program (NOP) certification for organically grown cotton is the highest possible measurement standard.

According to the 2016 Textile Exchange Organic Cotton report, the global market value of organic cotton is $15.76 billion and continues to grow as more brands and retailers expand their organic cotton collections. In the U.S., organic fiber sales represent about $1.3 billion (2015) which equals more than 37 percent of total organic non-food sales of $3.5 billion. The first molecularly verified organic cotton is expected to debut at retail in spring, 2018, using the “OrganiCott™” cotton fiber brand, providing a means for consumers to know where the organic cotton comes from, and that it follows a certified organic cotton process.

“In an environment where consumers are demanding more information about the origin and authenticity of their products, Applied DNA is proud to partner with Woolam Gin to integrate molecular tagging,” said Dr. James Hayward, president and CEO of Applied DNA. “SigNature T assures that the organic cotton grown and ginned in Texas is not blended with other cottons from different origins or with non-organic cotton, thereby remaining pure throughout the supply chain, all the way to the consumer.”

Continued Dr. Hayward, “The tagging of organic cotton evidences Applied DNA’s growing entrenchment in the U.S. cotton industry. The deployment of our tagging system, starting first with Pima cotton and continuing on to the Upland varietals and organic cotton reflects the importance industry participants today place on the use of technology to change the way that they source cotton and take control of their supply chain. Participating in the supply chain of certified organic cotton now sets the precedent for our participation in other certified organic supply chains, providing the assurance that both the manufacturers and consumers demand.”

Since 1999, on a world scale, there has been a four-fold increase in organic agricultural land (from 11 million to 43.7 million hectares in 2014 (FiBL & IFOAM – Organics International, 2016). The GOTS standard provides chain of custody assurance covering cotton processing, manufacturing, packaging, labeling, trading and distribution of home and apparel textiles made with organic fiber. The standard prohibits the use of toxic inputs during the processing stages and includes strong labor protections, including prohibitions on child labor. As of January 2017, more than 1.4 million workers were in more than 4,600 facilities in over 60 countries certified under GOTS.

“We are excited that GOTS has approved our ginning process utilizing the Applied DNA SigNature T molecular tag,” said Jimmy Wedel, president, Texas Organic Cotton Marketing. “Use of the molecular tag will give an added level of traceability, transparency and trust that are an important value to our cooperative and its members.” The Texas Organic Cotton Marketing Cooperative, based in West Texas High Plains area, grew almost 80 percent of all the organic cotton in the US in 2015.

“We are committed to a ginning process that authenticates our Texas organic cotton at its source,” said Kendall Harris, manager of Woolam Gin. “We take this commitment seriously and work hard to ensure that our organic cotton meets the highest standard to date. Woolam Gin is pleased to partner with Applied DNA and Control Union to complete our GOTS certification. This was a huge step and it is an honor to become the first GOTS v5.0 certified gin in the United States.”

About Woolam Gin
Woolam Gin is a third-generation family operated cotton gin in West Texas that has been in business since 1949. In 1991, we became the first gin in the United States to gin organic cotton.  We are committed to staying on the cutting edge of technology and, therefore, processing cotton of the highest standard in the ginning industry. We take great pride in ginning quality cotton that produces the best product and, therefore, maximizes profit for our producers. We look forward to working with our producers to help them achieve their quality goals. Woolam Gin believes “Quality Pays!”

About OrganiCott™
Organicott™ is a trademark owned by Himatsingka America.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature^®T and fiberTyping^®, targeted towards textiles and apparel, BackTrac™ and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017  which are available at www.sec.gov. APDN, undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contacts
investor contact: Sanjay Hurry, 212-838-3777
media contact: Angie Mathews, 781-639-4924
program contact: MeiLin Wan, Vice President, Textile Sales, 631-240-8849
web: www.adnas.com
twitter: @APDN

Company to Hold Conference Call and Webcast Today at 4:30 PM Eastern Time

STONY BROOK, N.Y., August 10, 2017 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”, or “the Company”), announced financial results for the fiscal 2017 third quarter ended June 30, 2017.

“We continued to make excellent progress in driving market adoption of our DNA technology platform in the fiscal third quarter while generating strong sales growth from our most established revenue-generating vertical from an initial cotton order for the upcoming ginning season,” said Dr. James A. Hayward, president and CEO of Applied DNA Sciences. “In textiles, we see evidence that our technology platform is gaining momentum as brands and retailers find it increasingly advantageous to provide assurances that the products on their shelves meet their product quality claims. Our recently announced, more favorable licensing agreement with key cotton partner Himatsingka America, Inc. (“Himatsingka”) illustrates the increasingly strategic role our molecular tag technology is playing in supporting manufacturers’ business goals. In addition, product and customer reviews of Bed, Bath and Beyond®’s Wamsutta® PimaCott® home fashions – manufactured by Himatsingka and incorporating our SigNature® T technology – demonstrate that authenticity is good for business. Beyond textiles, we also secured new revenue-generating awards in government/military and diagnostics verticals that broaden our opportunities for revenue growth.”

Third Quarter Financial Highlights:

• Revenues increased 175% for the third quarter of fiscal 2017 to $1.8 million, compared with $653 thousand reported in the third quarter of fiscal 2016, and increased 99% compared with revenues of $905 thousand reported in the second fiscal quarter ended March 31, 2017. The increase in revenue is primarily attributable to an increase in textile revenues.
• Total operating expenses were $4.2 million, compared with $3.9 million in the prior year’s quarter, an increase of approximately 7%. The increase in total operating expenses is primarily attributable to an increase associated with the write-off of an account receivable balance.
• Net loss for the quarter ended June 30, 2017 was $2.6 million, or $0.10 per share, compared with a net loss of $3.4 million, or $0.14 per share for the quarter ended June 30, 2016 and a net loss of $3.4 million, or $0.13 per share for the quarter ended March 31, 2017.
• Excluding non-cash expenses, Adjusted EBITDA for the quarter ended June 30, 2017 was negative $1.5 million, compared to negative Adjusted EBITDA of $2.5 million for the same quarter last fiscal year and negative Adjusted EBITDA of $2.7 million in the prior fiscal quarter. See below for information regarding non-GAAP measures.
• Net cash used in operating activities in the third quarter of fiscal 2017 was $1.9 million. This compares with $2.2 million in the corresponding prior-year period.

Continued Dr. Hayward, “Business development activity during the quarter was strong with pre-commercial opportunities growing to 14 active engagements at present from nine last quarter,” continued Dr. Hayward. “Recently concluded pilot projects, such as in Aloe vera, touch upon multiple markets, from food and supplements to pharmaceuticals and personal care.  As announced earlier this week, large-scale fertilizer tagging, offers the opportunity for large-scale deployments that address entire commercial ecosystems, as we do in cotton. While the timing of conversion from pilot to commercial contract is uncertain, we remain focused on expanding the basket of opportunities and on shortening sales cycles.“

As we look ahead, we see several areas of revenue growth. We believe that the start of the cotton ginning season and the growing “pull” we have experienced from brands and from new categories in our existing retail channels will help catalyze sales and improve working-capital to cash conversion. Business activity in non-cotton textile markets is also increasing as manufacturers of products utilizing synthetic fibers move to our technology platform to their sales advantage. Lastly, through our success in cotton we have been able to secure annual minimum revenue commitments from customers such as Loftex Home, LLC and GHCL Limited as licensees of CertainT™, our program that integrates our commercial platforms into a licensable strategy to generate royalty fees, in addition to revenues from the sale of DNA taggant and testing services. CertainT is today a cornerstone of our go-to-market strategy and a key component to building a diverse, recurring revenue base. With CertainT, we can participate not only at the front-end of the supply chain with the application of our molecular tags, but at the back-end of the value chain where the cumulative value-add is the highest and we can share in the economics with brands and retailers.”Concluded Dr. Hayward, “We have been moving aggressively to build the market for our technology platform and continue to expand our pipeline of opportunities. To help ensure that we have the financial flexibility to capture the opportunities before us today, we have entered into binding private placement subscription agreements with a key customer, as well as all executive officers and members of the board of directors. As we continue to build our business, we believe our successes today will be the foundation for our sustained growth tomorrow.”

Nine-Month Financial Highlights:

• Revenues for the first nine months of fiscal 2017 totaled $3.6 million, an increase of 41% from the same period in the prior year. This increase was the result of an increase in product revenues of $1.7 million, or 147%, primarily as a result of increased textile market sales. This increase was offset by a decrease in service revenues from two government contract awards, both of which expired during the fourth quarter of the prior fiscal year.
• Operating expenses for the nine months ended June 30, 2017 increased by $1.2 million or 10% for the same period last fiscal year. The increase is primarily attributable to an increase in stock-based compensation and bad debt expense, offset by a decrease in R&D due to the expiration of the two government contract awards.
• Net loss for the nine months ended June 30, 2017 was $10.0 million or $0.38 per share, compared with a net loss of $9.8 million or $0.41 per share for the nine months ended June 30, 2016.
• Excluding non-cash expenses and interest, Adjusted EBITDA improved for the nine months ended June 30, 2017 at a negative $6.6 million compared with an Adjusted EBITDA of negative $7.6 million for the same period last fiscal year. See below for information regarding non-GAAP measures.

Recent Business and Operational Highlights:

• On August 10, 2017, Applied DNA announced the start of production-scale tagging of bearings with a global manufacturer. The work will be performed under the newly awarded Rapid Innovation Fund (RIF) contract issued by the Office of the Secretary of Defense (OSD) on behalf of the Defense Logistics Agency (DLA).  This production-scale project is a follow-up to a successful pilot conducted under Applied DNA’s prior OSD RIF contract, completed in August of 2016, and reflects the Company’s ongoing efforts to commercialize processes and methodologies developed for Department of Defense (DoD) applications and apply them to commercial OEMs.
• On August 8, 2017, the Company announced that it had completed a pilot project for the large-scale molecular tagging of a fertilizer that was successfully tracked through the West African supply chain of the Rosier Group, SA, Belgium. The Company expects to begin shipments of fertilizer with molecular tags in early 2018.
• On July 18, 2017, Applied DNA announced that it had signed a new multi-year, exclusive CertainT platform license agreement with Loftex Home, LLC, a well-respected manufacturer of high-quality towels and home textiles, in connection with source verified recycled polyethylene terephthalate (PET). An expansion of the Company’s existing agreement with Loftex signed in March of this year, the new multi-year agreement is now exclusive for bath and beach towels in the United States, non-exclusive for plush throws and bath rugs  and provides for long term minimum annual revenues as well as trademark licensing royalties to Applied DNA.
• On July 11, 2017 as evidence of the Company’s continuing penetration of the non-cotton textile market, Applied DNA announced that it had signed a multi-year CertainT Platform license agreement with GHCL Limited, a global manufacturer of home textiles. The agreement provides for CertainT platform services in connection with source-verifiedPET and recycled PET (post consumer) in blended bed sheets, pillowcases, and shams sold in-store or online in the United States. GHCL has also licensed Applied DNA’s CertainT trademark for use on its products, as well as for promotional, marketing and sales materials. The agreement provides for minimum annual revenues as well as trademark licensing royalties to Applied DNA.
• On July 5, 2017, Applied DNA announced the addition of two sponsors to the Company’s leather traceability project with BLC Leather Technology Centre (BLC): Scottish Leather Group Ltd and Tong Hong Tannery. With these new additions, the research project now totals seven sponsors, including C&J Clark International and PUMA SE, among other global brands. The Research Project, initiated following the signing of a Research Agreement between the two companies, seeks to develop and validate a robust SigNature® T-based system to provide comprehensive and verifiable leather traceability, from farm to finished products.
• On June 28, 2017, the Company announced that it entered into subscription agreements for a private placement of its Common Stock with a group of investors, including a key customer and all of the Company’s Executive Officers and members of the Board of Directors.  No discounts or warrants were given to the investors. As a result of the private placement, the Company agreed to issue 1,025,574 shares of common stock at a price of $1.76 per share for total expected gross proceeds of $1,805,000.
• On June 27, 2017, Applied DNA announced the signing of a new, exclusive licensing agreement with Himatsingka America, Inc. with improved financial terms: 60-day payment terms, and discontinuation of revenue-sharing to its partners, yielding enhanced margins to Applied DNA.
• On June 27, 2017, the Company announced it had completed initial work under a funded contract with Lily of the Desert, a leading US-based producer of Aloe veraproducts, whose offerings include nutritional drinks, topical crèmes and gels. The pilot studies defined by the agreement are designed to demonstrate the feasibility of molecular tagging to create the industry’s first traceable and authenticated Aloe vera juices, from raw material to the manufacture of nutritional drinks and topical consumer products.
• On June 23, 2017, Applied DNA announced that it received an initial order to tag 27.5 million pounds of cotton to kick off the 2017/2018 ginning season, composed of three US cotton varietals. The three varietals are Pima, Delta and Acala, which fall under the Pimacott®, HomeGrown™ LoneStar™ and HomeGrown Acala™ programs. We believe the order demonstrates Applied DNA’s success in further entrenching SigNature T DNA in an established revenue-generating vertical and in extending the adoption of its proven technology platform.
• On June 6, 2017, the Company announced that it has been awarded a two-year, approximately $1.5 million competitive-bid development contract funded by the Office of the Secretary of Defense on behalf of the Defense Logistics Agency (DLA). The award expands current platforms to improve DoD counterfeit risk mitigation, and was granted via a Rapid Innovation Fund (RIF) that provides DLA with innovative technologies that can be rapidly inserted into acquisition programs to meet specific defense needs.
• On May 15, 2017, Applied DNA announced that it appointed Elizabeth M. Schmalz Ferguson to its Board of Directors. Ms. Ferguson was selected to serve based on her sterling track record of accomplishments as a strategist and product leader within the personal care industry. This appointment increased the total number of Board members to eight.
• On May 1, 2017, the Company announced the debut of its textile molecular tag technology, SigNature® T, in Bed Bath & Beyond®’s Wamsutta® line, featuring PimaCott®, at locations nationwide and online. SigNature T verifies that the Wamsutta home fashions products sold to consumers are pure Pima cotton, grown in the San Joaquin Valley, California. Products include comforters, pillow cases and shams.

Fiscal 2017 Third Quarter Conference Call Information
The Company will hold a conference call and webcast to discuss its fiscal 2017 third-quarter results on Thursday August 10, 2017 at 4:30 PM EST. To participate on the conference call, please follow the instructions below. While every attempt will be made to answer investors’ questions on the Q&A portion of the call, due to the large number of expected participants, not all questions may be answered.

To Participate:

Dial-in and ask to be joined to the Applied DNA Sciences earnings call.

• Participant Toll Free: 1-844-887-9402
• Participant Toll: 1-412-317-6798
• Live webcast: https://services.choruscall.com/links/apdn170810.html

Replay (available 1 hour following the conclusion of the live call):

• Participant Toll Free: 1-877-344-7529
• Participant Toll: 1-412-317-0088
• Participant Passcode: 10110378
• International replay Toll: https://services.choruscall.com/ccforms/replay.html
• Archived webcast: https://services.choruscall.com/links/apdn170810.html

Information about Non-GAAP Financial Measures
As used herein, “GAAP” refers to accounting principles generally accepted in the United States of America. To supplement our condensed consolidated financial statements prepared and presented in accordance with GAAP, this earnings release includes Adjusted EBITDA, which is a non-GAAP financial measure as defined in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a numerical measure of a company’s historical or future performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use this non-GAAP financial measure for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons of the performance and results of operations of our core business. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding the performance of our business by excluding non-cash expenses that may not be indicative of our recurring operating results. We believe this non-GAAP financial measure is useful to investors as it allows for greater transparency with respect to key metrics used by management in its financial and operational decision making.

“EBITDA”- is defined as earnings (loss) before interest expense, income tax expense and depreciation and amortization expense.

“Adjusted EBITDA”- is defined as EBITDA adjusted to exclude (i) stock-based compensation and (ii) other non-cash expenses.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature^® T and fiberTyping^®, targeted toward textiles and apparel, BackTrac™ and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017, and August 10, 2017, which are or will be available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, 212-838-3777, LHA, shurry@lhai.com
Media contact: Susan Forman, Dian Griesel Int’l., 212-825-3210, sforman@dgicomm.comweb: www.adnas.comtwitter: @APDN

APPLIED DNA SCIENCES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2017 (unaudited)	September 30, 2016
ASSETS
Current assets:
Cash and cash equivalents	$2,402,809	$4,479,274
Accounts receivable, net of allowance of $37,773 and $32,965 at June 30, 2017 and September 30, 2016, respectively	4,746,010	6,374,895
Stock subscriptions receivable	505,000	–
Inventories	376,520	297,759
Prepaid expenses and other current assets	113,234	200,006
Total current assets	8,143,573	11,351,934
Property, plant and equipment, net of accumulated depreciation of $1,565,153 at June 30, 2017 and $1,263,200 at September 30, 2016	589,656	792,499
Other assets:
Long term accounts receivables	–	1,535,000
Deposits	61,626	61,126
Deferred offering costs	–	13,986
Goodwill	285,386	285,386
Intangible assets, net of accumulated amortization of $607,047 and $423,649 at June 30, 2017 and September 30, 2016, respectively	1,342,502	1,525,900
Total Assets	$10,422,743	$15,565,831
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$1,730,560	$2,247,341
Deferred revenue	674,429	1,837,588
Total current liabilities	2,404,989	4,084,929
Long term accounts payable	–	215,500
Long term deferred revenue	–	900,000
Total liabilities	2,404,989	5,200,429
Commitments and contingencies
Stockholders’ Equity
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2017 and September 30, 2016	—	—
Series A Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2017 and September 30, 2016	—	—
Series B Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2017 and September 30, 2016	—	—
Common stock, par value $0.001 per share; 500,000,000 shares authorized at June 30, 2017 and September 30, 2016; 27,377,057 and 24,078,756 shares issued and outstanding as of June 30, 2017 and September 30, 2016, respectively	27,377	24,079
Additional paid in capital	242,808,854	234,158,711
Stock subscription receivable	(1,000,000)	—
Accumulated deficit	(233,818,477)	(223,817,388)
Total stockholders’ equity	8,017,754	10,365,402
Total Liabilities and Stockholders’ Equity	$10,422,743	$15,565,831

APPLIED DNA SCIENCES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

	Three Months Ended June 30, 2017	Three Months Ended June 30, 2016	Nine Months Ended June 30, 2017	Nine Months Ended June 30, 2016
Revenues:
Product revenues	$1,493,449	$295,867	$2,887,054	$1,167,452
Service revenues	303,933	357,029	718,709	1,382,880
Total revenues	1,797,382	652,896	3,605,763	2,550,332
Cost of revenues	232,348	180,559	804,552	735,692
Operating expenses:
Selling, general and administrative	3,402,817	2,576,891	10,534,105	8,185,149
Research and development	603,095	1,149,146	1,757,616	2,861,599
Depreciation and amortization	161,441	168,641	486,786	557,968
Total operating expenses	4,167,353	3,894,678	12,778,507	11,604,716
LOSS FROM OPERATIONS	(2,602,319)	(3,422,341)	(9,977,296)	(9,790,076)
Other income (expense):
Interest income, net	228	2,660	2,763	9,567
Other (expense) income , net	(8,758)	52,670	(26,556)	19,606
Net loss before provision for income taxes	(2,610,849)	(3,367,011)	(10,001,089)	(9,760,903)
Provision for income taxes	—	—	—	—
NET LOSS	$(2,610,849)	$(3,367,011)	$(10,001,089)	$(9,760,903)
Net loss per share-basic and diluted	$(0.10)	$(0.14)	$(0.38)	$(0.41)
Weighted average shares outstanding-
Basic and diluted	26,374,023	24,075,225	26,049,866	23,563,164

APPLIED DNA SCIENCES, INC. CALCULATION AND RECONCILIATION OF ADJUSTED EBITDA (Unaudited)

	Three Months Ended June 30, 2017	Three Months Ended June 30, 2016	Nine Months Ended June 30, 2017	Nine Months Ended June 30, 2016
Net Loss	$(2,610,849)	$(3,367,011)	$(10,001,089)	$(9,760,903)
Interest (income) expense, net	(228)	(2,660)	(2,763)	(9,567)
Depreciation and amortization	161,441	168,641	486,786	557,968
Stock based compensation expense	566,377	567,523	2,562,300	1,522,304
Bad debt expense	346,921	83,934	368,168	106,247
Total non-cash items	1,074,511	817,438	3,414,491	2,176,952
Consolidated Adjusted EBITDA (loss)	(1,536,338)	(2,549,573)	(6,586,598)	(7,583,951)

Project Aims to Scale-Up Commercial Platform for DNA Marking of Bearings

STONY BROOK, N.Y. August 10, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN), is commencing production-scale DNA marking of bearings with a global leader in the manufacture of bearings, at a domestic manufacturing facility.  The work will be performed under the newly awarded Rapid Innovation Fund (RIF) contract issued by the Office of the Secretary of Defense (OSD) on behalf of the Defense Logistics Agency (DLA), and reflects Applied DNA’s efforts to commercialize processes and methodologies developed for the Department of Defense and apply them to commercial OEMs.

This production-scale project is a follow-up to successful pilot conducted under Applied DNA’s prior OSD RIF contract, completed in August of 2016.  Through collaborative efforts led by the R&D team of the US-based bearing manufacturer, along with DLA Aviation’s subject matter experts from Richmond, VA, Applied DNA scientists tested and qualified blending SigNature® DNA into preservative lubricants used in the manufacturing of bearings. This innovative solution for DNA marking of bearings should provide little to no impact on the manufacturing process, which will be confirmed in the initial phase of production testing.

The immediate goal of the project is to assist in securing the Department of Defense supply chain, but Applied DNA believes the platform can easily be leveraged by commercial stakeholders, globally. Preservative lubricants are used in wide-ranging industrial applications, tool manufacturing, pneumatic equipment and small arms.

Bob MacDowell, Applied DNA Director, Government and Military Program Sales commented, “Our DNA-based solutions provide significant value in many different applications, allowing traceability to source along a supply chain. The most effective deployment of the DNA is at the point of manufacture, which creates the broadest platform possible and enables all stakeholders to benefit from the solution.”

“Agriculture, industrial equipment and the automotive industry are all focus markets for the bearings industry at large, which align well with Applied DNA’s roadmap for current markets to penetrate.  We are hopeful the success of this production project, will secure DLA’s bearing supply chain, and lead to larger opportunities in additional markets where both the bearing manufacturer and their customers can mutually benefit,” stated Dr. James Hayward, president and CEO of Applied DNA.The aerospace bearings market was valued at $7.88 billion in 2016 and is projected to reach $11.19 billion by 20221.  The overall global market for bearings, currently valued at greater than $84 billion, is projected to grow by 67 percent to $140 billion by 20222.

1. http://www.marketsandmarkets.com/Market-Reports/aerospace-bearing-market-191707655.html
2. https://www.alliedmarketresearch.com/bearings-market

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay Hurry, LHA Investor Relations,  212-838-3777, shurry@lhai.com
Media: Susan Forman, Dian Griesel Int’l, 212-825-3210, sforman@dgicomm.com
Program Contact: Bob MacDowell, 631-240-8823, bob.macdowell@adnas.com
web: www.adnas.com
twitter: @APDN

Project Aims to Prevent Fertilizer Adulteration and Secure Supply Chains to Global Farming Industry; Company Anticipates Initial Shipments to Begin in Early 2018

STONY BROOK, N.Y. and MOUSTIER, BE., August 8, 2017. Applied DNA Sciences, Inc. (“Applied DNA”, “the Company”, NASDAQ: APDN), announced the introduction of its molecular tag to the fertilizer industry in co-operation with Rosier S.A., a mineral fertilizer manufacturer based in Moustier, Belgium. Rosier sells high quality mineral fertilizers globally, and in Europe, through its exclusive distributor, Borealis LAT.

In September 2016, Applied DNA and Rosier launched a pilot to DNA-tag fertilizer pellets in order to detect the dilution of genuine fertilizer with sub-standard material within a given batch, and to be able to trace the batch to its original manufacturing location. Since the initiation of this study, the Company, in partnership with Rosier, has effectively marked fertilizer pellets and has successfully authenticated and detected the dilution of fertilizer with unmarked material in a variety of laboratory and in-field tests over a nine-month period.

A marked shipment of fertilizer has travelled through the supply chain in West Africa and pellets have been analyzed in the field utilizing Applied DNA’s in-field DNA detection technology (SigNify^® IF) to provide definitive real-time authentication of the SigNature^® DNA marks, ensuring that the fertilizer had not been adulterated with unmarked material. The pellets tested were proven to be genuine and demonstration of the technology gained further support for the use of molecular taggants to combat counterfeiting and to aid the many countries that are affected by adulterated fertilizer.

Adulterated fertilizer is recognized as a global problem. The Vietnam Fertilizer Association estimates that substandard fertilizer costs the country’s economy $2 billion dollars a year. In addition, 1,000 metric tons are seized annually for quality violations (1). In Uganda, a blind test revealed that urea on sale to farmers contained 33 percent less nitrogen than advertised (2) and in Tanzania, an estimated 40 percent of fertilizers are believed to be fakes (3).Tony Benson, managing director of Applied DNA Europe, stated: “Adulterated fertilizers have become a global supply chain problem of such impact, that bankers will no longer finance fertilizer purchases for some farmers.  Without these necessary funds, farmers cannot purchase fertilizer, leading to poor or failing crop yields, and financial disaster for the farmer. Regional banks expressed a willingness to finance DNA-tagged fertilizers in the future, and praised our in-country demonstrations of the power of molecular tags to protect fertilizer supply chains against dilution.”

Without appropriate restoration of the organic and mineral content of depleted soils, farmers often clear new land, contributing to the global deforestation problem. By improving the quality of arable land, farmers can turn less to deforestation, which represents as much as 30% of global greenhouse emissions. Africa, with a huge agricultural potential, uses less than 15 kgs of fertilizer per hectare, only a tenth of the global average. As a result, 75 percent of African soils are degraded, costing the continent $4 billion per year (4). FAO (Food and Agricultural Organization of the United Nations) forecasts the global fertilizer demand to be 199 million metric tons in 2019 (5).Dr. James Hayward, president and CEO of Applied DNA, stated: “The total addressable market for our platform in fertilizer is substantial, but well within our scalable capacity for global commercial ecosystems. Our manufacturing partner, Rosier, is well established, committed and familiar with the markets that will first pull our platform through fertilizer supply chains. We expect to identify initial customers and begin shipments of fertilizer with molecular tags in early 2018. We believe this is one of the most significant steps the global economy can take toward sustainable agronomy. Farming land where nutrient supplementation is in equilibrium with depletion by farming, will help to prevent deforestation.”

Willy Raymaekers, President and CEO of Rosier, stated: “We are very satisfied with the initial results of our co-operation with Applied DNA and are currently defining the next steps for further broadening the implementation of this innovative concept.”

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature^® T and fiberTyping^®, targeted toward textiles and apparel, BackTrac™ and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

About Rosier SA
Rosier produces and sells high quality mineral fertilizers in Europe, through its exclusive distributor Borealis LAT , and outside Europe to serve its customers in the most reliable way.  We provide farmers with suitable fertilizers considering individual crop and soil conditions. Embedded in the Base Chemicals business of Borealis, our aim is to strengthen our position in selected markets worldwide. With a highly motivated and professional team, we are close to our customers in agriculture. Our backward and forward integration result in supply security as well as high product and service standards.

Thanks to perfectly adapted and state-of-the-art industrial facilities, Rosier is able to offer environmentally friendly products that provide users with the best economical yield they can get. The ROSAFERT^® range primarily comprises simple and compound PK and NPK granulated fertilizers; Specialty fertilisers from the ROSALIQ^® and ROSASOL^® ranges are essentially designed for the greenhouse, foliar complementary nutrition or fertirrigation markets.

1. https://www.vietmaz.com/2016/06/fake-substandard-fertilizers-on-the-rise-in-vietnam/
2. https://www.theguardian.com/global-development-professionals-network/2015/aug/05/dodgy-fertiliser-is-keeping-uganda-hungry
3. http://www.thecitizen.co.tz/magazine/businessweek/40pc-of-fertilisers-fake–study/-/1843772/3120846/-/61ibdez/-/index.html
4. http://community.businessfightspoverty.org/profiles/blogs/kapil-mehan-breakthroughs-in-fertilizer-can-unlock-the-riches-in-
5. http://www.fertilizer.org/imis20/images/Library_Downloads/2016%20Global%20nitrogen%20fertiliser%20demand%20and%20supply.pdf?WebsiteKey=411e9724-4bda-422f-abfc-8152ed74f306&=404%3bhttp%3a%2f%2fwww.fertilizer.org%3a80%2fen%2fimages%2fLibrary_Downloads%2f2016+Global+nitrogen+fertiliser+demand+and+supply.pdf

Forward-Looking Statements
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
media contact: Cheryl Schneider, Dian Griesel Int’l, 212-825-3210, cschneider@dgicomm.com
program contact: Tony Benson, Managing Director, Applied DNA Europe, 44 (0) 7552 429341 tony.benson@adnas.com
web: www.adnas.comwww.borealisgroup.comwww.rosier.eu
twitter: @APDN

STONY BROOK, N.Y. (July 27, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), will host an investor call and simultaneous webcast on Thursday, August 10, 2017 at 4:30 PM ET to discuss its fiscal 2017 third quarter financial results.

Dr. James Hayward, president and CEO, and Beth Jantzen, CFO, plan to discuss the company’s performance and achievements for the quarter and outline key ongoing business initiatives for the balance of the 2017 fiscal year. Management’s commentary will be followed by a question-and-answer session. The investor call and webcast will be accompanied by a PowerPoint presentation, which will be made available on the company’s website at the start of the call.

For investors that are unable to attend the live call, call replay and webcast information is provided below.

To Participate:

Dial-in and ask to be joined to the Applied DNA Sciences earnings call.

• Participant Toll Free: 1-844-887-9402
• Participant Toll: 1-412-317-6798
• Live webcast: https://services.choruscall.com/links/apdn170810.html

Replay (available 1 hour following the conclusion of the live call):

• Participant Toll Free: 1-877-344-7529
• Participant Toll: 1-412-317-0088
• Participant Passcode: 10110378
• International replay Toll: https://services.choruscall.com/ccforms/replay.html
• Archived webcast: https://services.choruscall.com/links/apdn170810.html

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777
web: www.adnas.com
twitter: @APDN

First CertainT Recycled PET Towels to Arrive on U.S. Retail Shelves by Fourth Quarter of 2017

STONY BROOK N.Y. (July 18, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), has signed a new multi-year, exclusive license agreement with Loftex Home, LLC, a well respected manufacturer of high-quality towels and home textiles. Under a prior agreement announced in March 2017, Applied DNA provides CertainT™ platform services to Loftex to verify the authenticity and origin of recycled polyethylene terephthalate (rPET post-consumer) used in bath and beach towels. The first products using recycled PET verified with the CertainT platform are expected at retail by the fourth quarter of 2017. The new multi-year agreement between the two companies is now exclusive for bath and beach towels in the United States, non-exclusive for plush throws and bath rugs,  and provides for long term guaranteed minimum annual revenues as well as trademark licensing royalties to Applied DNA.

“Retailers, brands and consumers want to know where their products come from and where they are going,” said Charles Gaenslen, CEO of Loftex Home. “Sustainability product claims are central to our recycled PET programs and CertainT verifies our claims throughout the supply chain. Our initial agreement with Applied DNA evolved to be a long-term exclusive collaboration addressing the need for transparency in supply chains. The response from retailers based on our initial launch of our Fusion Fibers with CertainT collection announced in March exceeded our expectations, which is why we are expanding our use of recycled PET verified by the CertainT platform.”

CertainT provides a single platform to tag, test, track and trace products throughout a certified supply chain. Applied DNA’s molecular tag is extruded into the recycled components that create recycled PET fiber with no impact to performance or quality of the blended staple or filament PET yarns. Thereafter, any piece of the CertainT-tagged towels may be authenticated by detecting the molecular tag present in the recycled PET fiber, thus ensuring the recycled nature and origin of the fiber. Loftex will use recycled PET verified by CertainT to create recycled PET and cotton blended towels. The benefits of a blended recycled PET and cotton towels include less drying time and less water usage during washing, making for a more sustainable and time-saving end product.

“This new exclusive collaboration enables Loftex to provide an added level of trust to its customers,” said Dr. James Hayward, president and CEO of Applied DNA. “The ability to differentiate its brand in a competitive marketplace reinforces Loftex’ leadership as a transparent and responsible brand. As a licensee, Loftex also highlights the growing awareness and adoption of our CertainT program, which integrates our commercial platforms into a licensable strategy, with a public-facing trademark that stands for authenticity and performance.”

About Loftex Home
Loftex has established a global reputation for leadership in innovation, fashion, quality, sustainability and value as a supplier of bath towels, beach towels and plush throws. Founded in 1980, this privately held firm started as a beach towel factory and has steadily expanded in the international marketplace; Loftex is now one of the largest terry towel producers in the world. Product innovation is key to the company’s success. Loftex focuses on mid- to upper-end channels of distribution, offering excellent service and the finest quality products at competitive prices to major U.S. retail customers. The company develops products specifically to serve the needs of its major markets, all with the goal of engaging the ultimate consumer through touch, loft and overall tactile and visual appeal.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay Hurry, LHA Investor Relations, 212-838-3777
media contact: Angie Mathews, CGPR, 714-768-1140
program contact: MeiLin Wan, VP Textile Sales, 631-240-8849

CertainT platform ensures traceability, transparency and trust in responsible supply chains by tagging, testing and tracking recycled PET

STONY BROOK N.Y. (July 11, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), has signed a multi-year license agreement with GHCL Limited, a global manufacturer of home textiles, to provide CertainT™ platform services in connection with source-verified, polyethylene terephthalate (PET) and recycled PET (post consumer) in select home textile products. PET is the clear plastic best known for its use in water bottles, and is the most widely recycled plastic in the world. GHCL will use Applied DNA’s CertainT platform in connection with PET and/or recycled PET blended bed sheets, pillowcases, and shams products sold in-store or online in the United States. GHCL has also licensed Applied DNA’s CertainT trademark for use on its products, as well as for promotional, marketing and sales materials. The agreement provides for guaranteed minimum annual revenues as well as trademark licensing royalties to Applied DNA.

GHCL will use Applied DNA’s CertainT platform, a fully integrated supply chain platform for verifying PET and recycled PET authenticity from source to retail shelf. With this platform, GHCL assures that any of its textile products using PET and recycled PET will contain the original source raw materials.  Applied DNA will provide its patented and proprietary tagging, testing and tracking services to GHCL as a CertainT licensee.

“As the need for sustainable and recyclable textiles continues to increase in demand from our customers, we want to offer products that provide true traceability that go beyond a paper document. In these uncertain times, our customers deserve and expect certainty,” stated Neeraj Jalan, Business Head, Home Textiles, for GHCL. “The collaboration with Applied DNA provides a means to produce and supply our customers with source-verified, recycled products, as well as access to new authentication technologies in synthetic fibers that Applied DNA develops over the course of our relationship.”

As part of the platform, Applied DNA’s molecular tag is extruded into recycled components that create recycled PET fiber, with no impact to performance or quality of the fiber or filament yarns. Thereafter, any piece of CertainT-tagged textiles can be forensically authenticated by detecting the molecular tag in the recycled PET fiber, ensuring its authenticity and origin.

“We bring ‘CertainT’ in uncertain times especially as many brands and retailers need to fulfil their sustainability goals by the year 2020,” said Dr. James Hayward, president and CEO of Applied DNA.  “The CertainT platform will help GHCL produce innovative products utilizing an efficient and trusted traceability system with a fair return. Differentiating their brand in the marketplace through use of our CertainT trademark will signify to consumers the products comply with our supply chain platform and are verifiably made from recycled fibers.”

About GHCL
GHCL is a well-diversified group with footprints in Chemicals, Textiles and Consumer Products segment. GHCL’s Textiles division is a vertically integrated manufacturing facility with spinning, wider-width weaving, continuous fabric processing, and cut & sew facilities for manufacturing premium quality bed linen. GHCL is one of India’s leading manufacturers of Home Textiles, with in-house spinning unit having capability to manufacture multiple varieties of 100% cotton and blended yarns at various facilities.GHCL is known as perennial innovators in bed linen category with some of recent innovations in the category of ‘sheets’ which include the PERFECT FIT, EASYSHEET, microTWILL, CELLIANT, EXL Wrinkle Free Sheets, VERSATILE–Reversible Sheets, Soft Wash Percale and Sustainable Fibre dyed sheets.GHCL’s Home Textiles products are predominantly exported worldwide to countries like United Kingdom, United States of America, Australia, Canada, Germany and other European Union countries as well.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay Hurry, LHA Investor Relations, 212-838-3777
media contact: Angie Mathews, CGPR, 714-768-1140
program contact: MeiLin Wan, 631-240-8849

STONY BROOK, N.Y. (June 21, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN), is pleased to announce that  MeiLin Wan, Vice President of Textiles, received a 2017 Outstanding 50 Asian Americans in Business Award at the organization’s 16th annual dinner gala in New York City on June 20th.

The Outstanding 50 Asian Americans in Business Award Gala includes a wide array of Asian ethnicities that represent a microcosm of elite Asian American business owners, professionals and corporate executives across the United States. The award committee identifies and selects outstanding leaders who have built a successful business or who have distinguished themselves in their community.

Recognized for her contributions to secure supply chain solutions and services to assure quality and enable responsible sourcing practices for textile customers globally, Wan’s work fulfills the promise of, “keeping textiles real and safe.”  She has more than 25 years of experience in the biotechnology, consumer products, and personal care industries, specializing in marketing, sales, strategic and international management.

Today, Wan is actively working to initiate new platforms such as CertainT™ to safeguard supply chains against product recalls, and liability, while maintaining profitability and market differentiation. From 2014 to present, Wan has led Applied DNA’s efforts to tag, test, and trace over 160 million pounds of U.S. grown cotton, resulting in the launch of products sold under the PimaCott® brand in over 1,700 stores throughout the United States and Canada. In addition, she leads the team for creating and driving commercial strategies to develop innovative textile applications in synthetics, recycled cellulosic, rayon, wool, cashmere, silk and many other fiber, yarn and fabric products. Focusing on excellence in marketing, sales, and customer service, Wan is the key business manager for multinational partners and clients including Himatsingka, Loftex, Louis Dreyfus Company, Martin Guitar, Nissha Printing Company, Solvay, and other Fortune 500 companies.

MeiLin Wan receives the 2017 Outstanding 50 Asian Americans in Business Award from John Wang, founder and president of Asian American Business Development Center

“MeiLin has been such an asset to our team,” said Dr. James Hayward, president and CEO of Applied DNA. “She has brought a real creative force to our science, pushing our innovations forward and growing our textile business, which is instrumental in the growth of our company. We are very proud of her work and congratulate her on this great honor.”The 2017 award gala cumulatively has honored over 700 successful Asian Americans representing over 50 industries and professions. In recognizing this year’s role models from the Asian American business community, John Wang, president of Asian American Business Development Center (AABDC) also highlighted the emergence of the New Majority as America’s ethnic minorities are poised to become the biggest combined demographic bloc in coming years. “We’re proud to honor high-achieving Asian Americans in business, and excited to join with Latinos and African Americans to form the new Mainstream Economy,” said Wang.

Asian American Business Development Center (AABDC)
The Asian American Business Development Center, Inc. is a 501(c) (3) non-profit organization established in 1994. It assists Asian American businesses in strengthening their capacity to compete in the mainstream market, to expand business opportunities and to promote recognition of Asian American businesses’ contributions to the general economy.

About Applied DNA
Applied DNA is a provider of DNA-based supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics. We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, track, and trace products, to help assure authenticity, origin, traceability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track- and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor Relations:  Sanjay Hurry, 212-838-3777Media: Angie Mathews, 714-768-1140
Program Contact: John Shearman, 631-240-8838

Security Intelligence Provided to Global Police

STONY BROOK, NY. May 15, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics, is helping break up international gangs of car thieves.BMW implemented a mandatory DNA marking program in Sweden for new vehicles in February 2016. Supported by multiple insurance brands, the program has proven effective in curbing thefts by over 80% and facilitating prosecution of “chop shop” criminals. To gangs with international distribution networks, the collective value of a chopped car’s components can be worth more than the car previously sold as new and intact. Once marked with SigNature® DNA, components can be traced back to a specific vehicle, and there have been numerous cases where this has assisted police already.

A recent investigation revealed that of 60 stolen car parts found in Lithuania, 17 were marked with SmartDNA (the Scandinavian brand of SigNature DNA) and so could be traced back to their source and original owner.

According to SmartDNA’s Leif Svensson, the creation of this program was necessitated by the increasing rate of car part theft in Sweden.

“Last year alone, our country was due to start about 3 thousand pre-trial investigations for car theft. And in each case, the victim’s or insurance company’s losses amounted to between 15 and 20 thousand euros. Therefore, it was decided to spare no investment in new technologies – mandatory for all new BMW cars and marking systems,” said Svensson, highlighting the fact that Swedish authorities detained 39 Lithuanians for car part theft in 2016.

“This is the message to thieves…DNA technology will be available anywhere, because the police are without borders,” stated Aleksejus Gubenko, Kaunas County Police 3rd Division Chief. Gubenko demonstrated the technology at a media conference, and explained how their colleagues from Sweden donated equipment that will become an antidote for various forms of theft.

Tony Benson, Managing Director for Applied DNA Sciences Europe, further added: “It is well known that stolen car parts are shipped around the world and often sold on the internet at a bargain price. When customers purchase our SigNature DNA marker they are also buying a security intelligence service, since when stolen car parts are recovered we carry out forensic analysis and map where the items are stolen from and the location they were found, and so build up an intelligence picture which we then share with law enforcement agencies enabling them to capture not only the initial car thieves but the whole international criminal supply chain. To give you an idea of the scale of our security intelligence, we have carried out forensic analysis on thousands of items recovered by law enforcement agencies enabling the imprisonment of 114 individuals who have received prison sentences of over 540 years with many more cases in the pipeline which makes a significant difference.”

Dr. James Hayward, president and CEO of Applied DNA stated: “Imagine the irony of a bargain-hunting car enthusiast, hunting the web for bargain “original parts” that do not void the manufacturer’s warrantee.  These are original, but stolen parts that are likely abused as they traverse the criminal supply chain. Worse, the system promulgates collaboration in gang-based enterprises that can fund other activities with more deleterious impact on humanity.”

Source: Kauno Diena

About Applied DNA Sciences
Applied DNA Sciences makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainTTM” platform can be used to identify, tag, track, and trace products, to help assure authenticity, origin, traceability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track- and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contacts
Investor contact: Debbie Bailey, 631-240-8817, debbie.bailey@adnas.com
media contact: Susan Forman, Dian Griesel Int’l., 212-825-3210, sforman@dgicomm.com
program contacts: Tony Benson, Managing Director, EMEA, +44 7552 429341, tony.benson@adnas.com
Gordon Hope, Director of Security Solutions, 631-240-8850, gordon.hope@adnas.com
web: www.adnas.com
twitter: @APDN